TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scius Pharma Support AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
818
|
936
|
1,371 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-295
|
59
|
448 |
| EBITDA |
-298
|
59
|
448 |
| Total assets |
1,058
|
1,501
|
1,847 |
| Current assets |
1,058
|
1,501
|
1,847 |
| Current liabilities |
121
|
86
|
160 |
| Equity capital |
937
|
1,415
|
1,687 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
88.6%
|
94.3%
|
91.3% |
| Turnover per employee |
818
|
936
|
1,371 |
| Profit as a percentage of turnover |
-36.1%
|
6.3%
|
32.7% |
| Return on assets (ROA) |
-27.9%
|
3.9%
|
24.3% |
| Current ratio |
874.4%
|
1745.3%
|
1154.4% |
| Return on equity (ROE) |
-31.5%
|
4.2%
|
26.6% |
| Change turnover |
-185
|
-393
|
590 |
| Change turnover % |
-18%
|
-30%
|
76% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.